Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Jazz Pharmaceuticals, Inc
Woman and Man Max 99 years
Jazz Pharmaceuticals, Inc
Update Il y a 4 ans
A clinical trial undertaken around the world in adult patients with excessive daytime sleepiness . These patients are randomly given a drug or an inactive drug to increase their ability to stay awake throughout the day
To evaluate the efficacy of JZP-110 administered once daily for up to 12 weeks in doses of 75, 150, and 300 mg compared to placebo in the treatment of excessive sleepiness in adult subjects with narco...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Jazz Pharmaceuticals, Inc
Update Il y a 4 ans
Single- and Multiple-Dose Study to Compare the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Sodium Oxybate (Xyrem®) in Subjects with Moderate to Severe Essential Tremor
To determine the relationship between drug plasma levels and safety, tolerability, and efficacy in subjects with moderate to severe essential tremor after single and multiple doses of sodium oxybate.
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Jazz Pharmaceuticals, Inc
Update Il y a 4 ans
A Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Study of Xyrem® (sodium oxybate) in Subjects with Fibromyalgia
To evaluate the safety and efficacy of Xyrem (sodium oxybate) oral solution at 4.5 g/night and 6 g/night compared to placebo for the treatment of fibromyalgia in a randomized, double-blind, placebo co...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Jazz Pharmaceuticals, Inc
Update Il y a 4 ans
A long term clinical trial undertaken around the world in adult patients to treat Excessive Sleepiness in Subjects with Narcolepsy or Obstructive Sleep Apnea
To evaluate the safety and tolerability of JZP-110 administered once daily for up to 52 weeks in doses of 75, 150, and 300 mg.
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Jazz Pharmaceuticals, Inc
Update Il y a 4 ans
A clinical trial undertaken around the world for treating excessive daytime sleepiness in subjects with obstructive sleep apnea. These patients are randomly given a drug or an inactive drug to increase their ability to stay awake throughout the day
To evaluate the efficacy of JZP-110 administered once daily for up to 12 weeks in doses of 37.5, 75, 150, and 300 mg compared to placebo in the treatment of excessive sleepiness in adult subjects with...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Jazz Pharmaceuticals, Inc
Update Il y a 4 ans
A Phase 2a, Open-label, Proof-of-Concept Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Intranasal Clonazepam in Adult Subjects with Epileptic Seizures
To determine the minimum effective dose (MED) of intranasal clonazepam, defined as the lowest dose that can effectively reduce epileptiform activity in adult epilepsy subjects over the 24 hours follow...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Jazz Pharmaceuticals, Inc
Update Il y a 4 ans
A clinical study to investigate the efficacy and safety of Defibrotide compared with Best Supportive Care in the prevention of Hepatic Veno-Occlusive Disease in adult and pediatric patients Undergoing Hematopoietic Stem Cell Transplant. Ensayo clínico para investigar la eficacia y seguridad de Defibrotide en comparación con el mejor tratamiento de soporte en la prevención de la enfermedad venooclusiva hepática en pacientes adultos y pediátricos sometidos a un trasplante hematopoyético de células madre
The primary objective of the study is to compare the efficacy of defibrotide vs Best Supportive Care for the prevention of Veno-Occlusive Disease (VOD) as measured by VOD-free survival by Day +30 post...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Jazz Pharmaceuticals, Inc
Update Il y a 4 ans
Treatment of excessive sleepiness in adult patients with obstructive sleep apnea; to increase the ability to stay awake throughout the day
To evaluate the efficacy of JZP-110 administered once daily compared to placebo in the treatment of excessive sleepiness in adult subjects with OSA.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Jazz Pharmaceuticals, Inc
Update Il y a 4 ans
A clinical trial to evaluate the effects of JZP-110 (study drug) on driving performance in subjects with excessive sleepiness due to Narcolpesy
1. To evaluate the effect of JZP-110 on driving performance
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Jazz Pharmaceuticals, Inc
Update Il y a 4 ans
A Long-Term, Open-Label Safety and Efficacy Study of Xyrem (sodium oxybate) in Subjects with Fibromyalgia
The primary objective of this study is to assess the safety of Xyrem (sodium oxybate) in long term use (up to 38 weeks) in subjects completing a double-blind controlled trial of Xyrem for the treatmen...
Country
None
organs
None
Specialty
None
unknown
More information